In this issue:
2024 ACC Expert Consensus Decision Pathway: Treating HFrEF
Implications of AF for GDMT in patients with HF
Implementation science to achieve equity in HF care
New insights in acute HF
EOL care for patients with ESHF
Change of restriction to Riociguat
Tenecteplase 40 mg to be discontinued
FDA clears AI-based algorithm to detect HF
Heart Health Check Toolkit
Therapeutic inertia
ATAGI advice on seasonal influenza vaccines in 2024
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)